Constantine S. Tam, Stephen Opat, Shirley D’Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G. Owen, Paula Marlton, Bjorn E.Wahlin, Ramon Garcia Sanz, HelenMcCarthy, StephenMulligan, Alessandra Tedeschi, Jorge J. Castillo, Jaroslaw Czyz, Carlos Fernandez de Larrea, David Belada, Edward Libby, Jeffrey V. Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trneny, Monique C. Minnema, Christian Buske, Veronique Leblond, Judith Trotman, Wai Y. Chan, Jingjing Schneider, Sunhee Ro, Aileen Cohen, Jane Huang, and Meletios Dimopoulos, for the ASPEN Investigators
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic WM: the ASPEN study
Submitted 14 May 2020; accepted 26 June 2020; prepublished online on Blood First Edition 31 July 2020. DOI 10.1182/blood.2020006844